Allergan leaves Ireland as parent company re-domiciles to US
The move reverses a major corporate decision from 2015, when Allergan shifted its headquarters from the US to Ireland following a merger with Actavis.
Changes to US tax policy under Donald Trump have made such schemes far less attractive to US companies.
AbbVie CEO Rob Michael said the 2017 U.S. tax reforms—cutting corporate tax rates and removing inversion incentives—were key to the company's $60 billion acquisition of Allergan in 2020 and its recent re-registration in the US.
'Tax reform allowed us to acquire Allergan and re-domicile it into the US,' he told a public news conference.
While Allergan's Westport plant remains operational and continues to manufacture Botox, the company's corporate headquarters are now back in America.
In 2023, Allergan reported a turnover of $5 billion, with nearly ¾ of sales coming from the US.
The re-domiciling could just be the beginning: US pharma companies with major Irish operations—such as Eli Lilly and Johnson & Johnson—are increasingly investing back in the states amid political uncertainty.
AbbVie plans to invest over $10 billion in the US over the next decade, encouraged by Trump tax reforms and recent incentives in the 'One Big Beautiful Bill.'
Trump has also threatened a 200% tariff if pharma companies don't shift operations back to America.
Ireland is currently home to over 900 US multinationals, many of which are in pharma, tech, and finance.
These firms employ more than 200,000 people directly and indirectly support many more.
Allergan's move raises worry about a potential exodus, especially if future US policies continue to punish offshore operations.
While Ireland still offers a favourable corporate tax rate and strong regulatory environment, the tide of US reshoring incentives could pose long-term risks to its role as a global hub for American business.
See More: Allergan, Botox, Pharmaceuticals, US Trade Tariffs, Westport
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Irish Examiner
19 minutes ago
- Irish Examiner
The Open Diary: Turnberry question isn't going away
Turnberry hasn't staged an Open Championship since 2009 but, if it's been out of sight then it is in no way out of mind. Bought by Donald Trump in 2014, the question as to whether it will host again is one that crops up again and again. R&A chief executive Mark Darbon reiterated on Wednesday the 'logistical challenges' making another staging there difficult and pointed to issues surrounding road, rail and accommodation infrastructure at a venue that held half the crowd expected at Royal Portrush this week. But the suspicion remains that Trump and the noise around the US president remains a sticking point. 'I met a couple of months ago with Eric Trump and some of the leadership from the Trump golf organisation and from Turnberry,' said Darbon. 'We had a really good discussion. 'I think they understand clearly where we're coming from. We talked through some of the challenges that we have so we've got a good dialogue with them.' Cheap at the price? There's talk of The Open generating a couple of hundred million pounds for the local economy here this week, and anyone putting their hands in their pockets to take in some of the action over what is now a week-long affair will probably understand why. Sporting events just don't come cheap anymore. A basic ticket to get inside the grounds here on day one costs €115, rising to €150 by Sunday. Premium packages went for a lot more than that, of course. First things first, though. You have to get there. Fuel for the car is one thing, then there's the €25 per day for the park-and-ride. A programme will set you back €14, a cheeseburger €12.70 and a pint of Guinness or lager a stiff €9. All this on the back of the story that went viral earlier this week of the Ramore restaurant group in Portrush that hiked up their prices to eye-watering levels before partially bringing them back down in the face of the criticism. We haven't dared venture into the on-course merchandise store yet. Deep breath… Open gives way to Sons of Ulster Saturday evening's event by Portrush Sons of Ulster, involving 70 bands and roughly 2,000 people, has prompted the third round of The Open, due to finish around the same time, to be brought forward by 15 minutes. Darbon stressed that the R&A and its retinue are guests in the community this week and that they have worked with various stakeholders to ensure that both events can 'run as seamlessly as possible'. He called the changes 'marginal adjustments' but opted against giving a direct answer when asked to respond to reports recently that the R&A had offered the other event's organisers £20,000 to alter their schedule to avoid any crossover. 'We're actually contributing some incremental costs to support what I just said, the seamless operation of both events. We try and be good citizens in the communities in which we operate when we come to town. "When you're staging a major event, security is always… Security and the safety of your guests and the experience of your guests is always a prime consideration. This is no different. That's why that multi-agency approach is so critical.'
Irish Examiner
19 minutes ago
- Irish Examiner
Firing of Fed Reserve chief ‘highly unlikely', says Trump
President Donald Trump has said it is 'highly unlikely' he will fire Federal Reserve chairman Jerome Powell 'unless he has to leave for fraud'. The statement came less than 24 hours after Mr Trump indicated in a private meeting that he is leaning in favour of dismissing the head of the US central bank. Mr Trump confirmed that he discussed the 'concept' of dismissing Mr Powell in a meeting with about a dozen Republicans, who had gathered at the White House on Tuesday to discuss crypto legislation in the House of Representatives. Jerome Powell leads the US central bank (Julia Demaree Nikhinson/AP) 'Almost every one of them said I should,' Mr Trump said on Wednesday during an Oval Office meeting. US stocks were shaky after the news broke, as such a move could help Wall Street get the lower interest rates that it loves but would also risk a weakened Fed unable to make the unpopular moves needed to keep inflation under control. Meanwhile, House Speaker Mike Johnson stopped short of calling for Mr Powell to be fired, saying he was not certain about the 'executive authority' involved. But he did say 'new leadership would be helpful at the Fed'. 'I've been unhappy with the leadership there personally,' Mr Johnson told reporters on Wednesday.
Irish Independent
20 minutes ago
- Irish Independent
Pharma is crucial to the Irish economy, Simon Harris tells US bosses in Zoom call
Ireland's position is that it should be addressed in the course of general discussions on tariffs between the EU and USA - and not set aside for later attention. US president Donald Trump has threatened separate sanctions on pharma, which could be very great in light of his stated intention to put a 30pc tariff on European goods in genral. The online meeting was an opportunity for the Tánaiste to hear first-hand the views of the pharmaceutical sector, his officials said. The Zoom call comes at a critical juncture in EU-US trade talks. Mr Harris said it was "a chance to gain key insights." He added: "Ireland is clear that the integrated supply chain in pharma products between the EU and the US supports - rather than threatens - our collective transatlantic economic security. 'Ireland's position is that the treatment of pharma should be within negotiations with the EU on an agreement in principle and we have made this point on both sides of the Atlantic over the recent weeks and months,' Mr Harris said, adding that there is no doubt that pharma "is a crucial sector for our economy'. He repeated his argument that US pharmaceutical companies are here for many reasons rather than tax treatment alone. "They have access to a highly talented, skilled labour market, they have access too to an EU market of over 450 million people,' he said. "The value that the industry places on this access and their bases in Ireland was clear to me from the call." He added: "Ultimately when it comes to pharma, this is about achieving the best outcomes for patients and citizens on both sides of the Atlantic. 'It is because of that that the main focus at this stage must be on avoiding an escalatory higher tariff outcome that will be deeply detrimental to both the EU and the US." It is fair to say that the EU "has shown considerable constraint when it comes to counter tariffs" so far, Mr Harris said. "This h underscores our desire to reach a negotiated settlement that results in mutually beneficial transatlantic trade and investment as soon as possible before August 1,' he said.
